BMC MAT Quick Start vs PursueCare

This app offers healthcare providers the latest evidence-based guidance for treating opioid and alcohol use disorders (OUD and AUD) assisting in the initiation of medications such as buprenorphine and naltrexone. This is an essential tool for those starting patients on these medications, providing step-by-step clinical decision trees and valuable resources for managing not only AUD and OUD but acute and chronic pain for patients already on buprenorphine or naltrexone. With interactive tools, treatment protocols, and patient messaging features, this app empowers clinicians to deliver life-saving care while improving while improving treatment outcomes for substance use disorders. More than 46 million people aged 12 or older (or 16.5% of the US population) met the DSM-5 criteria for having a substance use disorder (SUD) in the past year based on the latest data from the 2021 National Survey on Drug Use and Health (NSDUH). However, only about 6% of people received any treatment for their SUD. Providing addiction treatment, including the use of FDA- approved medications and behavioral health therapies, has been shown to save lives and increase retention in treatment. The interactive clinical algorithms in this app walk you through each step of the clinical decision- making process to help you care for patients with an OUD or AUD. The clinical algorithms are also available in PDF format for easy viewing along with ability to securely text message patient tools to get started on buprenorphine. Additionally, several other clinical tools and resources related to SUD are included. BMC MAT QUICK START FEATURES: CLINICAL ALGORITHMS * Buprenorphine Initiation Guide: Decision trees for starting patients with an opioid use disorder on buprenorphine who are not currently physically dependent on opioids, opioid-dependent and not yet in withdrawal, and opioid-dependent and in active withdrawal. * Initiation of Extended-Release Injectable Buprenorphine: Guidance for starting a patient on new weekly and monthly formation formulations of extended-release injectable buprenorphine. * Naltrexone Initiation for Alcohol Use Disorder: Guidance for starting a patient on naltrexone for the treatment of alcohol use disorder. * Naltrexone Initiation for Opioid Use Disorder: Guidance for starting a patient on naltrexone for the treatment of opioid use disorder. Includes strategies for managing opioid withdrawal during the required “washout period” prior to starting naltrexone and avoiding precipitated withdrawal. * Pain Management While on Buprenorphine for Opioid Use Disorder: Guidance for managing acute and chronic pain in patients already on buprenorphine for opioid use disorder. * Pain Management While on Naltrexone: Guidance for managing acute pain (both anticipated and unanticipated) and chronic pain in patients already on naltrexone for opioid use disorder. * New! List of medication classes to assist in the management of opioid withdrawal symptoms. CLINICAL TOOLS * DSM-5 criteria for diagnosis of an opioid use disorder * Clinical Opiate Withdrawal Scale (COWS) to measure the severity of opioid withdrawal * Alcohol Use Disorders Identification Test (AUDIT-C) to identify risky drinking patterns PATIENT HANDOUTS * Buprenorphine Initiation Guide: A guide to give to patients who are starting buprenorphine in the home or community setting. Note: This app is designed exclusively for the use of healthcare providers. This app is not intended for use to diagnose a disease or to cure, mitigate, treat, or prevent any condition or disease. It is the responsibility of the treating clinician to rely on their own experience and knowledge about their specific patient to determine dosages and the best treatment for that patient.

PursueCare provides virtual, judgment-free addiction recovery services for individuals struggling with alcohol, opioids, stimulants, and other addictive substances. We also provide support for co-occurring mental health conditions. Same-day admissions are available so you can connect with care and start treatment right away. You’ll receive immediate access to a team of addiction and mental health specialists including physicians, psychiatric providers, counselors, pharmacists, and case managers. Our in-house pharmacy, PursueCareRx, can fill your prescriptions and deliver them directly to you. We accept many private insurances as well as Medicare and Medicaid. What’s Inside the App - A personalized treatment plan tailored to your recovery for alcohol and/or other substances. - Private video appointments with licensed medical and counseling staff that fit your schedule. - Access to FDA-authorized digital therapeutics for 24/7 recovery support. - Low-cost medications shipped directly to you. - Ability to access details of your treatment plan and chat with your care team. How to Get Started 1. Download the app and create an account. Fill out your profile by answering some basic questions. 2. A Patient Access Specialist will contact you to complete your profile, discuss insurance and/or payment options, and set up your first appointment. 3. Meet with your clinical team. They will assess your needs, create a personalized treatment plan, and write any necessary prescriptions. 4. Meet with your Case Manager who can help keep you on track and connect you with helpful tools and resources to support your recovery. 5. Start your journey to better health and a better life. What to Expect Treatment happens on your time, when and where it is convenient for you. You will have access to on-demand check-ins with your Case Manager, at-home drug screening, self-assessments, and regular therapy and MAT appointments. During these appointments, we encourage you to bring up any questions or concerns you might have. PursueCare does not let any third parties track user data, and we do not disclose protected health information for any reason other than to facilitate care. We do not collect and sell any data to third parties for advertising or other similar purposes. We do not record patient visits or store data from patient video visits on their device. PursueCare has earned The Joint Commission’s Gold Seal of Approval® for Accreditation by demonstrating continuous compliance with its performance standards.